Summary
Robert Lee is a scientist with eight years of experience specializing in antibody discovery and cell therapy, including phage and yeast display, bispecific antibody design, immune cell engagers, CAR‑T, and TIL approaches. He earned a PhD in Chemical Engineering from Stanford, contributed to six publications, and is inventor on two patents for novel antibody targets and bispecific formats. At Lyell and in academia he focused on enhancing CAR‑T cytotoxicity, proliferation, and stemness while applying multicolor flow cytometry, viral transduction, and functional immune assays. Now in stealth‑mode biotech, he blends rigorous protein engineering with translational cell therapy development, and his informal “mad scientist” electronics hobby hints at hands‑on tinkering and experimental creativity beyond the bench.
8 years of coding experience
4 years of employment as a software developer
Bachelor of Science (B.S.), Chemical and Biomolecular Engineering, Summa Cum Laude, Bachelor of Science (B.S.), Chemical and Biomolecular Engineering, Summa Cum Laude at Cornell University
Doctor of Philosophy - PhD, Chemical Engineering, Doctor of Philosophy - PhD, Chemical Engineering at Stanford University